Formation of a ribonucleoprotein complex of mouse hepatitis virus involving heterogeneous nuclear ribonucleoprotein A1 and transcription- regulatory elements of vital RNA

Virology

Volumn 264, Issue 1, 1999, Pages 115-124

  Zhang, Xuming ^a,b   Li, Hsin Pai ^a   Xue, Wenmei ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NUCLEAR PROTEIN; RIBONUCLEOPROTEIN; VIRUS RNA;

ARTICLE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RNA BINDING; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0033544382     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9970     Document Type: Article

References (61)

1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1994;Wiley, New York.
2. Baker S. C., Lai M. M.-C. An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J. 9:1990;4173-4179.
3. Baric R. S., Nelson G. W., Fleming J. O., Deans R. J., Keck J. G., Casteel N., Stohlman S. A. Interactions between coronavirus nucleocapsid protein and viral RNAs: Implications for viral transcription. J. Virol. 62:1988;4280-4287.
4. Ben-David Y., Bani M. R., Chabot B., De Koven A., Bernstein A. Retroviral insertions downstream of the heterogeneous rebonucleoprotein A1 gene in erythroleukemia cells: Evidence that A1 is not essential for cell growth. Mol. Cell. Biol. 12:1992;4449-4455.
5. Bennet M., Pinol-Roma S., Staknis D., Dreyfuss G., Reed R. Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol. Cell. Biol. 12:1992;3165-3175.
6. Black A. C., Luo J., Chun S., Bakker A., Fraser J. K., Rosenblatt J. D. Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1. Virus Genes. 12:1996;275-285.
7. Black A. C., Luo J., Watanabe C., Chun S., Bakker A., Faser J. K., Morgan J. P., Rosenblatt J. D. Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J. Virol. 69:1995;6852-6858.
8. Budzilowicz C. J., Wilczynski S. P., Weiss S. R. Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3′-end of the viral mRNA leader sequence. J. Virol. 53:1985;834-840.
9. Burd C. G., Dreyfuss G. RNA binding specificity of hnRNP A1: Significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13:1994;1197-1204.
10. Buvoli M., Biamonti G., Tsoulfas P., Bassi M. T., Ghetti A., Riva S., Morandi C. cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res. 16:1988;3751-3770.
11. Buvoli M., Cobianchi F., Riva S. Interaction of hnRNP A1 with snRNPs and pre-mRNAs: Evidence for a possible role of A1 RNA annealing activity in the first steps of spliceosome assembly. Nucleic Acids Res. 20:1992;5017-5025.
12. Cartegni L., Maconi M., Morandi E., Cobianchi F., Riva S., Biamonti G. hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J. Mol. Biol. 259:1996;337-348.
13. Chabot B., Blanchette M., Lapierre I., Branche H. An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol. Cell. Biol. 17:1997;1776-1786.
14. Cobianchi F., Sen Gupta D. N., Zmudzka B. Z., Wilson S. H. Structure of rodent helix-destabilizing protein revealed by cDNA cloning. J. Biol. Chem. 261:1986;3536-3543.
15. Dreyfuss G., Matunis M. J., Pinol-Roma S., Burd C. G. hnRNP protein and the biogenesis of mRNA. Annu. Rev. Biochem. 62:1993;289-321.
16. Furuya T., Lai M. M. C. Three different cellular proteins bind to the complementary sites on the 5′-end positive- and 3′-end negative-strands of mouse hepatitis virus RNA. J. Virol. 67:1993;7215-7222.
17. Hirano N., Fujiwara K., Hino S., Matsumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:1974;298-302.
18. Izzauralde E., Mattaj I. W. RNA export. Cell. 81:1995;153-159.
19. Jeong Y. S., Makino S. Evidence for coronavirus discontinuous transcription. J. Virol. 68:1994;2615-2623.
20. Kiledjian M., Dreyfuss G. Primary structure and binding activity of the hnRNP U protein: Binding RNA through RGG box. EMBO J. 11:1992;2655-2664.
21. Kim Y.-N., Jeong Y. S., Makino S. Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology. 197:1993;53-63.
22. Konings D. A. M., Bredenbeek P. J., Noten J. F. H., Hogeweg P., Spaan W. J. M. Differential premature termination of transcription as a proposed mechanism for the regulation of coronavirus gene expression. Nucleic Acids Res. 16:1988;10849-10860.
23. Lai M. M. C. Coronavirus leader RNA-primed transcription: An alternative mechanism to RNA splicing. BioEssays. 5:1986;257-260.
24. Lai M. M. C. Coronavirus: Organization, replication and expression of genome. Annu. Rev. Microbiol. 44:1990;303-333.
25. Lai M. M. C. Cellular factors in the transcription and replication of viral RNA genomes: A parallel to DNA-dependent RNA transcription. Virology. 244:1998;1-12.
26. Lai M. M. C., Baric R. S., Brayton P. R., Stohlman S. A. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus-a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA. 81:1984;3626-3630.
27. Lai M. M. C., Brayton P. R., Armen R. C., Patton C. D., Pugh C., Stohlman S. A. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from the hepatotropic strain MHV 3. J. Virol. 39:1981;823-834.
28. Lai M. M. C., Cavanagh D. The molecular biology of coronaviruses. Advances in Virus Research. 1997;Academic Press, New York. p. 1-100.
29. Lai M. M. C., Patton C. D., Baric R. S., Stohlman S. A. Presence of leader sequences in the mRNA of mouse hepatitis virus. J. Virol. 46:1983;1027-1033.
30. Lamond A., Sproat B. S. Isolation and characterization of ribonucleoprotein complexes. Higgins S. J., Hames B. D. RNA Processing: A Practical Approach. 1996;103-140 Oxford Univ. Press, New York.
31. Lee H.-J., Shieh C.-K., Gorbalenya A. E., Koonin E. V., La Monica N., Tuler J., Bagdzhadzhyan A., Lai M. M.-C. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology. 180:1991;567-582.
32. Leibowitz J. L., Wilhelmsen K. C., Bond C. W. The virus specific intracellular RNA species of two murine coronaviruses: MHV A59 and MHV-JHM. Virology. 114:1981;39-51.
33. Li H.-P., Huang P., Park S., Lai M. M. C. Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J. Virol. 73:1999;772-777.
34. Li H.-P., Zhang X., Duncan R., Comai L., Lai M. M. C. Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl. Acad. Sci. USA. 94:1997;9544-9549.
35. Liao C.-L., Lai M. M. C. Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 68:1994;4727-4737.
36. Lin Y.-J., Lai M. M. C. Deletion mapping of a mouse hepatitis virus defective-interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J. Virol. 67:1993;6110-6118.
37. Lin Y. J., Zhang X., Wu R. C., Lai M. M. C. The 3′ untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J. Virol. 70:1996;7236-7240.
38. Makino S., Joo M., Makino J. K. A system for study of coronavirus mRNA synthesis: A regulated, expressed subgenomic defective-interfering RNA results from intergenic site insertion. J. Virol. 65:1991;6031-6041.
39. Makino S., Lai M. M. C. Evolution of the 5′-end of genomic RNA of murine coronaviruses during passages in vitro. Virology. 169:1989a;227-232.
40. Makino S., Lai M. M. C. High-frequency leader sequence switching during coronavirus defective-interfering RNA replication. J. Virol. 63:1989b;5285-5292.
41. Matunis E. L., Matunis M. J., Dreyfuss G. Association of individual hnRNP proteins and snRNPs with nascent transcripts. J. Cell Biol. 121:1993;219-228.
42. Mayeda A., Krainer A. R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell. 68:1992;365-375.
43. Mayeda A., Munroe S. H., Caceres J. F., Krainer A. R. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J. 13:1994;5483-5495.
44. Pinol-Roma S., Dreyfuss G. Transcription-dependent and transcription-independent nuclear transport of hnRNP proteins. Science. 253:1991;312-314.
45. Pinol-Roma S., Dreyfuss G. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature. 355:1992;730-732.
46. Pollard V. W., Michael W. M., Nakielny S., Siomi M. C., Wang F., Dreyfuss G. A novel receptor-mediated nuclear protein import pathway. Cell. 86:1996;985-994.
47. Sawicki S. G., Sawicki D. L. Coronavirus transcription: Subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 64:1990;1050-1056.
48. Sethna P. B., Hung S. L., Brian D. A. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. Natl. Acad. Sci. USA. 86:1989;5626-5630.
49. Shieh C.-K., Lee H.-J., Yokomori K., La Monica N., Makino S., Lai M. M. C. Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J. Virol. 63:1989;3729-3736.
50. Shieh C.-K., Soe L. H., Makino S., Chang M.-F., Stohlman S. A., Lai M. M. C. The 5′-end sequence of the murine coronavirus genome: Implications for multiple fusion sites in leader-primed transcription. Virology. 156:1987;321-330.
51. Siomi H., Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J. Cell Biol. 129:1995;551-560.
52. Smith D. B., Johnson K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
53. Spaan W., Delius H., Skinner M., Armstrong J., Rottier P., Smeekens S., van der Zeijst B. A. M., Siddell S. G. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J. 2:1983;1839-1844.
54. Stohlman S. A., Baric R. S., Nelson G. N., Soe L. H., Welter L. M., Deans R. J. Specific interaction between coronavirus leader RNA and nucleocapsid protein. J. Virol. 62:1988;4288-4295.
55. van der Most R. G., de Groot R. J., Spaan W. J. M. Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: A study of coronavirus transcription initiation. J. Virol. 68:1994;3656-3666.
56. Weighardt F., Biamonti G., Riva S. Nucleo-cytoplasmic distribution of human hnRNP proteins: A search for the targeting domains in hnRNP A1. J. Cell Sci. 108:1995;545-555.
57. Will C. L., Kastner B., Luehrmann R. Analysis of ribonucleoprotein interactions. Higgins S. J., Hames B. D. RNA Processing: A Practical Approach. 1996;141-177 Oxford Univ. Press, New York.
58. Yang X., Bani M. R., Lu S. J., Rowan S., Ben-David Y., Chabot B. The A1 and A1B proteins of heterogeneous nuclear ribonucloparticles modulate 5′ splice site selection in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;6924-6928.
59. Zhang X., Lai M. M. C. Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: Implications for the mechanism of RNA transcription and recombination. J. Virol. 68:1994;6626-6633.
60. Zhang X., Lai M. M. C. Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: Correlation with the amounts of subgenomic mRNA transcribed. J. Virol. 69:1995;1637-1644.
61. Zhang X., Liao C.-L., Lai M. M. C. Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription, both in trans and in cis. J. Virol. 68:1994;4738-4746.